Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Merck settles Vioxx lawsuits for $4.85 billion

But drug firm maintains it was not at fault over arthritis drug.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Authors

Related links

Related links

Related links in Nature Research

Cardiovascular Medicine

Related external links

Merck news release detailing Vioxx settlement

Lanier Law firm news release on Vioxx settlement

Garret FitzGerald, Chair, Department of Pharmacology, University of Pennsylvania

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wadman, M. Merck settles Vioxx lawsuits for $4.85 billion. Nature (2007). https://doi.org/10.1038/450324b

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/450324b

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing